Xenetic Biosciences (XBIO) Change in Receivables (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Change in Receivables for 6 consecutive years, with $372507.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables rose 170.51% year-over-year to $372507.0, compared with a TTM value of $758273.0 through Sep 2025, up 158.67%, and an annual FY2024 reading of -$181874.0, down 481.02% over the prior year.
- Change in Receivables was $372507.0 for Q3 2025 at Xenetic Biosciences, up from $260234.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $442496.0 in Q2 2023 and bottomed at -$876734.0 in Q4 2023.
- Average Change in Receivables over 3 years is $35478.8, with a median of $164338.0 recorded in 2024.
- The sharpest move saw Change in Receivables crashed 427.06% in 2024, then skyrocketed 170.51% in 2025.
- Year by year, Change in Receivables stood at -$876734.0 in 2023, then skyrocketed by 126.67% to $233866.0 in 2024, then surged by 59.28% to $372507.0 in 2025.
- Business Quant data shows Change in Receivables for XBIO at $372507.0 in Q3 2025, $260234.0 in Q2 2025, and -$108334.0 in Q1 2025.